Myeloma minute;Pomalidomide Alone or in Combination with Low
Publicado: Jue Ene 07, 2010 4:09 pm
ASH 2009: Paul Richardson
A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib
http://myeloma.org/ArticlePage.action?t ... goryId=454
Texto:
http://myeloma.org/ArticlePage.action?t ... 81&aTab=-1
abrazos
A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib
http://myeloma.org/ArticlePage.action?t ... goryId=454
Texto:
http://myeloma.org/ArticlePage.action?t ... 81&aTab=-1
abrazos